SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to a major expansion in its partnership with NVIDIA to integrate QNX safety-certified software into industrial, medical, and robotics edge AI platforms. The community is buzzing with optimism, with many long-term shareholders viewing this as a pivotal validation of the company's turnaround and its transition into a key player for physical AI and autonomous systems.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing massive, parabolic gains driven by a technical short squeeze and highly concentrated institutional ownership that has limited the available float. Community sentiment is deeply polarized, with retail traders debating the sustainability of the move while warning of an inevitable, sharp correction if the company initiates a share offering or if major stakeholders decide to liquidate.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense volatility and community division after a rapid parabolic surge followed by a steep price collapse that erased the vast majority of its recent gains. While some participants are calling for a short squeeze or treating the drop as a discount buying opportunity, others are warning of a classic pump-and-dump scheme and highlighting official investigations into potential market manipulation.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as retail sentiment surges following the termination of a dilutive equity facility and regulatory approval to remove pattern day trading restrictions. The community is actively discussing a potential short squeeze, citing significant institutional interest and price momentum as the stock moves toward key breakout levels.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is trending as investors react to a government executive order aimed at expediting the review of psychedelic treatments, including ibogaine. The community is actively debating the company's ability to capitalize on this news, with bulls pointing to their GMP-compliant supply chain and potential pipeline, while bears remain skeptical about the firm's history of dilution and long-term financial viability.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is gaining momentum as investors pivot toward its "Physical AI" narrative, bolstered by a strong Q4 earnings surprise that featured record sensor shipments and the strategic acquisition of StereoLabs. The community is actively discussing Ouster's potential to dominate critical infrastructure sectors and defense applications as domestic supply chain preferences grow, though traders remain cautious about managing volatility around upcoming hardware product cycles.

BlackBerry is seeing significant investor momentum driven by the company's expanding role in software-defined vehicle architecture and edge AI, particularly through its QNX operating system. The community is actively discussing a major contract extension with the Canadian government and high-profile partnerships with tech giants, while bullish investors emphasize the long-term potential of the company's growing royalty backlog.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp. is drawing intense interest from the investment community as a high-growth drone and defense technology play following its public debut. Investors are actively debating the company's valuation and long-term potential, frequently comparing its execution and revenue backlog to industry peers while highlighting geopolitical tailwinds as a primary catalyst for the stock's momentum.

Alaska Air Group, Inc. is a holding company, which engages in the provision of air transportation services. It operates through the following segments: Alaska Airlines, Hawaiian Airlines, and Regional. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo. The Hawaiian Airlines segment refers to scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. The Regional segment consists of Horizon's and other third-party carriers’ scheduled air transportation on E175 aircraft for passengers under CPAs. The company was founded in 1985 and is headquartered in Seattle, WA.

Alaska Air Group Inc.

Alaska Air Group is trending as investors digest the airline's latest earnings report, which was heavily impacted by rising fuel costs and operational challenges. While the community is actively debating the company's long-term strategy and guidance suspension, many traders are closely monitoring these levels for potential buying opportunities.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is surging as investors closely monitor positive clinical trial results for its autoimmune CAR-T pipeline, specifically focusing on miv-cel's potential as a first-in-class treatment. The community is actively debating the company's valuation, recent institutional accumulation, and the increasing likelihood of an acquisition by a larger pharmaceutical player as it advances its registrational trials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GIS: General Mills at a 15-Year Low: This Is What Generational Oversold Looks Like  
 
Adding General Mills to the packaged-foods long thesis alongside Conagra and Campbell&#39;s. Same sector, same setup, same capitulation playbook... and if you&#39;ve been following the last two posts, you already know the macro framework I&#39;m working with. If not, go read them. The short version: the entire consumer staples complex is being priced like it&#39;s in terminal decline, and I think that&#39;s wrong. 
 
General Mills. Cheerios. Pillsbury. Nature Valley. Betty Crocker. This is a name that has been in American pantries for over a century, and the monthly chart just printed a retest of price levels it last traded at in 2011. Fifteen years of brand equity, acquisitions, and cash flow growth... erased from the tape. 
 
The technical setup: 
– Monthly chart has the stock sitting right at the midline of my buy zone ($33.10 floor, $38.59 ceiling)... at $35.28, this is exactly where I start engaging 
– Monthly RSI at 20.6. For context, that&#39;s lower than what CPB and CAG printed at their respective lows... and those are already at generational extremes 
– Monthly stochastics at 6.2... I&#39;m running out of ways to say &quot;washed&quot; w/o repeating myself, but this is as stretched as the rubber band gets on a monthly timeframe 
– Trading 35% below the 200-month SMA ($54.07), and the monthly lower Bollinger Band at $33.72 lines up almost perfectly with the buy zone floor... the technical levels are stacking on top of each other 
– The degree of mean-reversion potential here is extraordinary for a defensive name 
– Volume on the monthly bar is spiking at 108M+ shares... elevated and distribution-heavy, the same forced-selling, capitulation signature I&#39;ve flagged in the rest of the sector 
 
The positioning: 
Short the Jun $32.50 puts... breakeven in the low-$31 range on assignment, which would put me at price levels that haven&#39;t been visited since the GFC recovery. I&#39;m getting paid to wait at a level the chart hasn&#39;t seen in over a decade. On the offensive side, I&#39;m long Jan 2028 LEAPS at various strikes, giving the thesis nearly two years to play out without worrying about short-term noise. I&#39;ll be building this position over time as the setup develops. 
 
The thesis: 
The same one driving my CAG and CPB longs: peak narrative hate in packaged foods, elevated short interest across the sector, extreme valuation compression, and the very real probability of M&amp;A consolidation that catches the shorts on the wrong side. These are cash-flowing businesses w/decades-old brands and distribution moats being valued like distressed assets. The pendulum has swung too far, and when it snaps back -- whether via mean reversion, a takeout bid, or simply one decent earnings print -- the move is going to be violent because, IMO, the exit door is far too small for the short base that&#39;s built up. 
 
Bear case: 
Same risks as the rest of the sector. Private label pressure, GLP-1 demand headwinds, commodity cost inflation on margins, and the possibility that &quot;cheap&quot; gets cheaper before a catalyst materializes. If $33.10 breaks, the buy zone floor and the monthly lower Bollinger Band fail simultaneously... that&#39;s where I reassess size and positioning. My LEAPS give me duration to absorb short-term noise, and my put strikes give me assignment at a level I&#39;d back up the truck at anyway. 
 
Three names, one thesis: $CAG, $CPB, GIS. The sector is hated, the valuations are historic, and insiders are buying. I&#39;m positioning accordingly. 
 
My opinion only... not financial advice. ALWAYS do your own homework. Giddy up and GLTA.

Max A'Million Via All-in

Juan Stockton

Pao_Light

bearhunter

Dave

StockTwits Web

General Mills, Inc.

Conagra Brands Inc

Campbell Soup Co.

: General Mills at a 15-Year Low: This Is What Generational Oversold Looks Like  
 
Adding General Mills to the packaged-foods long thesis alongside Conagra and Campbell's. Same sector, same setup, same capitulation playbook... and if you've been following the last two posts, you already know the macro framework I'm working with. If not, go read them. The short version: the entire consumer staples complex is being priced like it's in terminal decline, and I think that's wrong. 
 
General Mills. Cheerios. Pillsbury. Nature Valley. Betty Crocker. This is a name that has been in American pantries for over a century, and the monthly chart just printed a retest of price levels it last traded at in 2011. Fifteen years of brand equity, acquisitions, and cash flow growth... erased from the tape. 
 
The technical setup: 
– Monthly chart has the stock sitting right at the midline of my buy zone ($33.10 floor, $38.59 ceiling)... at $35.28, this is exactly where I start engaging 
– Monthly RSI at 20.6. For context, that's lower than what CPB and CAG printed at their respective lows... and those are already at generational extremes 
– Monthly stochastics at 6.2... I'm running out of ways to say "washed" w/o repeating myself, but this is as stretched as the rubber band gets on a monthly timeframe 
– Trading 35% below the 200-month SMA ($54.07), and the monthly lower Bollinger Band at $33.72 lines up almost perfectly with the buy zone floor... the technical levels are stacking on top of each other 
– The degree of mean-reversion potential here is extraordinary for a defensive name 
– Volume on the monthly bar is spiking at 108M+ shares... elevated and distribution-heavy, the same forced-selling, capitulation signature I've flagged in the rest of the sector 
 
The positioning: 
Short the Jun $32.50 puts... breakeven in the low-$31 range on assignment, which would put me at price levels that haven't been visited since the GFC recovery. I'm getting paid to wait at a level the chart hasn't seen in over a decade. On the offensive side, I'm long Jan 2028 LEAPS at various strikes, giving the thesis nearly two years to play out without worrying about short-term noise. I'll be building this position over time as the setup develops. 
 
The thesis: 
The same one driving my CAG and CPB longs: peak narrative hate in packaged foods, elevated short interest across the sector, extreme valuation compression, and the very real probability of M&A consolidation that catches the shorts on the wrong side. These are cash-flowing businesses w/decades-old brands and distribution moats being valued like distressed assets. The pendulum has swung too far, and when it snaps back -- whether via mean reversion, a takeout bid, or simply one decent earnings print -- the move is going to be violent because, IMO, the exit door is far too small for the short base that's built up. 
 
Bear case: 
Same risks as the rest of the sector. Private label pressure, GLP-1 demand headwinds, commodity cost inflation on margins, and the possibility that "cheap" gets cheaper before a catalyst materializes. If $33.10 breaks, the buy zone floor and the monthly lower Bollinger Band fail simultaneously... that's where I reassess size and positioning. My LEAPS give me duration to absorb short-term noise, and my put strikes give me assignment at a level I'd back up the truck at anyway. 
 
Three names, one thesis: 

, GIS. The sector is hated, the valuations are historic, and insiders are buying. I'm positioning accordingly. 
 
My opinion only... not financial advice. ALWAYS do your own homework. Giddy up and GLTA.